David Penson was named chair of the Science & Quality Council at the American Urological Association. He will assume the role of chair-elect on June 1 and begin his two-year term as chair on June 2018.
NCI awarded ATCC a five-year indefinite-delivery/indefinite-quantity contract to support the Division of Cancer Epidemiology and Genetics' Molecular Epidemiology Assay Support program.
The International Labour Organization voted on Wednesday to delay the decision on whether to cut ties with Big Tobacco until November.
Thomas Lynch was named chief scientific officer at Bristol-Myers Squibb.
The NCCN Oncology Research Program has awarded grants for its first-ever multi-industry collaborative project, soliciting investigator-initiated proposals to research the effectiveness of Boehringer Ingelheim's afatinib in combination with other drugs to treat lung and head and neck cancers.
By the time its annual conference concludes on March 25, the National Comprehensive Cancer Network aims to have 100 medical centers and practices that deliver chemotherapy committed to Just Bag It: The NCCN Campaign for Safe Vincristine Handling.
European Society For Medical Oncology said it will take over the organization of the Targeted Anticancer Therapies Congress, with the aim of expanding its educational offer and ensure that professionals are kept up-to-date with the latest drug developments to improve outcomes for cancer patients.
CancerLinQ LLC, a wholly-owned nonprofit subsidiary of the American Society of Clinical Oncology, and the Oncology Nursing Society announced the formation of the CancerLinQ Ambassadors Program.
Boone Hospital Center, one of Missouri's top hospitals and part of BJC HealthCare, is the first affiliate in the network and will work with Siteman Cancer Center to provide access to cancer prevention and control strategies and genomic and genetic testing in the mid-Missouri area.
The Karmanos Cancer Institute and Wayne State University School of Medicine will launch the nation's largest study of African American cancer survivors to better understand disproportionately high incidence and mortality from cancer and its impact on this specific patient population.
